SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-006807
Filing Date
2021-11-03
Accepted
2021-11-03 17:48:01
Documents
2
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 10255
2 POA JAY DUKER AS COO 3 jayduker_poa2021-2a.txt EX-24 3087
  Complete submission text file 0001562180-21-006807.txt   14929
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 1ST ST. #400 CAMBRIDGE MA 02142
Business Address
Duker Jay S. (Reporting) CIK: 0001630864 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 211376849